NASDAQ:KYMR | Insider Transactions — Page 6 | Kymera Therapeutics, Inc.

KYMR Insider Transactions — Page 6

1,189 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 501–600; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
Atlas Venture Fund X, L.P.TenPercentOwner2024-03-11Sale37,180.0$42.77
Atlas Venture Associates X, LLCTenPercentOwner2024-03-11Sale37,180.0$42.77
ATLAS VENTURE ASSOCIATES X, L.P.TenPercentOwner2024-03-11Sale37,180.0$42.77
Atlas Venture Opportunity Fund I, L.P.TenPercentOwner2024-03-11Sale37,180.0$42.77
Atlas Venture Associates Opportunity I, L.P.TenPercentOwner2024-03-11Sale37,180.0$42.77
Atlas Venture Associates Opportunity I, LLCTenPercentOwner2024-03-11Sale37,180.0$42.77
Booth BruceDirector2024-03-11Sale1,045.0$43.42
Booth BruceDirector2024-03-11Sale7,837.0$42.77
Booth BruceDirector2024-03-11Sale5,122.0$43.42
Booth BruceDirector2024-03-11Sale37,180.0$42.77
Gollob JaredChief Medical Officer2024-03-04Sale216.0$43.26
Gollob JaredChief Medical Officer2024-03-04Sale1,106.0$42.39
Gollob JaredChief Medical Officer2024-03-04Sale2,022.0$41.41
Jacobs Bruce N.Chief Financial Officer2024-03-04Sale255.0$43.26
Jacobs Bruce N.Chief Financial Officer2024-03-04Sale1,301.0$42.39
Jacobs Bruce N.Chief Financial Officer2024-03-04Sale2,378.0$41.41
Gollob JaredChief Medical Officer2024-02-27Sale400.0$45.0
Albers Jeffrey W.Director2024-02-21Sale4,385.0$39.05
Albers Jeffrey W.Director2024-02-20Sale615.0$39.07
Gollob JaredChief Medical Officer2024-02-09Sale7,398.0$36.09
Gollob JaredChief Medical Officer2024-02-09Sale38,739.0$35.39
Albers Jeffrey W.Director2024-01-23Sale10,000.0$30.05
Chiniara EllenChief Legal Officer2024-01-04Sale3,295.0$22.58
BIOTECHNOLOGY VALUE FUND L PDirector,Other2023-11-03Purchase10,106.0$14.07
BVF PARTNERS L P/ILDirector,Other2023-11-03Purchase10,106.0$14.07
BVF INC/ILDirector,Other2023-11-03Purchase10,106.0$14.07
BIOTECHNOLOGY VALUE FUND II LPDirector,Other2023-11-03Purchase10,106.0$14.07
LAMPERT MARK NDirector,Other2023-11-03Purchase10,106.0$14.07
Biotechnology Value Trading Fund OS LPDirector,Other2023-11-03Purchase10,106.0$14.07
BVF Partners OS Ltd.Director,Other2023-11-03Purchase10,106.0$14.07
BVF I GP LLCDirector,Other2023-11-03Purchase10,106.0$14.07
BVF II GP LLCDirector,Other2023-11-03Purchase10,106.0$14.07
BVF GP HOLDINGS LLCDirector,Other2023-11-03Purchase10,106.0$14.07
BIOTECHNOLOGY VALUE FUND L PDirector,Other2023-11-03Purchase83,708.0$14.07
BVF PARTNERS L P/ILDirector,Other2023-11-03Purchase83,708.0$14.07
BVF INC/ILDirector,Other2023-11-03Purchase83,708.0$14.07
BIOTECHNOLOGY VALUE FUND II LPDirector,Other2023-11-03Purchase83,708.0$14.07
LAMPERT MARK NDirector,Other2023-11-03Purchase83,708.0$14.07
Biotechnology Value Trading Fund OS LPDirector,Other2023-11-03Purchase83,708.0$14.07
BVF Partners OS Ltd.Director,Other2023-11-03Purchase83,708.0$14.07
BVF I GP LLCDirector,Other2023-11-03Purchase83,708.0$14.07
BVF II GP LLCDirector,Other2023-11-03Purchase83,708.0$14.07
BVF GP HOLDINGS LLCDirector,Other2023-11-03Purchase83,708.0$14.07
BIOTECHNOLOGY VALUE FUND L PDirector,Other2023-11-03Purchase103,885.0$14.07
BVF PARTNERS L P/ILDirector,Other2023-11-03Purchase103,885.0$14.07
BVF INC/ILDirector,Other2023-11-03Purchase103,885.0$14.07
BIOTECHNOLOGY VALUE FUND II LPDirector,Other2023-11-03Purchase103,885.0$14.07
LAMPERT MARK NDirector,Other2023-11-03Purchase103,885.0$14.07
Biotechnology Value Trading Fund OS LPDirector,Other2023-11-03Purchase103,885.0$14.07
BVF Partners OS Ltd.Director,Other2023-11-03Purchase103,885.0$14.07
BVF I GP LLCDirector,Other2023-11-03Purchase103,885.0$14.07
BVF II GP LLCDirector,Other2023-11-03Purchase103,885.0$14.07
BVF GP HOLDINGS LLCDirector,Other2023-11-03Purchase103,885.0$14.07
BIOTECHNOLOGY VALUE FUND L PDirector,Other2023-11-02Purchase26,772.0$11.64
BVF PARTNERS L P/ILDirector,Other2023-11-02Purchase26,772.0$11.64
BVF INC/ILDirector,Other2023-11-02Purchase26,772.0$11.64
BIOTECHNOLOGY VALUE FUND II LPDirector,Other2023-11-02Purchase26,772.0$11.64
LAMPERT MARK NDirector,Other2023-11-02Purchase26,772.0$11.64
Biotechnology Value Trading Fund OS LPDirector,Other2023-11-02Purchase26,772.0$11.64
BVF Partners OS Ltd.Director,Other2023-11-02Purchase26,772.0$11.64
BVF I GP LLCDirector,Other2023-11-02Purchase26,772.0$11.64
BVF II GP LLCDirector,Other2023-11-02Purchase26,772.0$11.64
BVF GP HOLDINGS LLCDirector,Other2023-11-02Purchase26,772.0$11.64
BIOTECHNOLOGY VALUE FUND L PDirector,Other2023-11-02Purchase132,016.0$11.64
BVF PARTNERS L P/ILDirector,Other2023-11-02Purchase132,016.0$11.64
BVF INC/ILDirector,Other2023-11-02Purchase132,016.0$11.64
BIOTECHNOLOGY VALUE FUND II LPDirector,Other2023-11-02Purchase132,016.0$11.64
LAMPERT MARK NDirector,Other2023-11-02Purchase132,016.0$11.64
Biotechnology Value Trading Fund OS LPDirector,Other2023-11-02Purchase132,016.0$11.64
BVF Partners OS Ltd.Director,Other2023-11-02Purchase132,016.0$11.64
BVF I GP LLCDirector,Other2023-11-02Purchase132,016.0$11.64
BVF II GP LLCDirector,Other2023-11-02Purchase132,016.0$11.64
BVF GP HOLDINGS LLCDirector,Other2023-11-02Purchase132,016.0$11.64
BIOTECHNOLOGY VALUE FUND L PDirector,Other2023-11-02Purchase57,618.0$11.64
BVF PARTNERS L P/ILDirector,Other2023-11-02Purchase57,618.0$11.64
BVF INC/ILDirector,Other2023-11-02Purchase57,618.0$11.64
BIOTECHNOLOGY VALUE FUND II LPDirector,Other2023-11-02Purchase57,618.0$11.64
LAMPERT MARK NDirector,Other2023-11-02Purchase57,618.0$11.64
Biotechnology Value Trading Fund OS LPDirector,Other2023-11-02Purchase57,618.0$11.64
BVF Partners OS Ltd.Director,Other2023-11-02Purchase57,618.0$11.64
BVF I GP LLCDirector,Other2023-11-02Purchase57,618.0$11.64
BVF II GP LLCDirector,Other2023-11-02Purchase57,618.0$11.64
BVF GP HOLDINGS LLCDirector,Other2023-11-02Purchase57,618.0$11.64
Caughey ElaineChief Business Officer2023-03-02Sale164.0$31.4
Caughey ElaineChief Business Officer2023-03-02Sale550.0$30.88
Gollob JaredChief Medical Officer2023-03-02Sale297.0$31.4
Gollob JaredChief Medical Officer2023-03-02Sale1,001.0$30.88
Jacobs Bruce N.Chief Financial Officer2023-03-02Sale314.0$31.4
Jacobs Bruce N.Chief Financial Officer2023-03-02Sale1,056.0$30.88
Booth BruceDirector2023-01-12Sale21,592.0$30.29
Booth BruceDirector2023-01-12Sale77,128.0$30.29
Atlas Venture Fund X, L.P.TenPercentOwner2023-01-12Sale21,592.0$30.29
Atlas Venture Associates X, LLCTenPercentOwner2023-01-12Sale21,592.0$30.29
ATLAS VENTURE ASSOCIATES X, L.P.TenPercentOwner2023-01-12Sale21,592.0$30.29
Atlas Venture Opportunity Fund I, L.P.TenPercentOwner2023-01-12Sale21,592.0$30.29
Atlas Venture Associates Opportunity I, L.P.TenPercentOwner2023-01-12Sale21,592.0$30.29
Atlas Venture Associates Opportunity I, LLCTenPercentOwner2023-01-12Sale21,592.0$30.29
Atlas Venture Fund X, L.P.TenPercentOwner2023-01-12Sale77,128.0$30.29
Atlas Venture Associates X, LLCTenPercentOwner2023-01-12Sale77,128.0$30.29
ATLAS VENTURE ASSOCIATES X, L.P.TenPercentOwner2023-01-12Sale77,128.0$30.29